DRIZALMA Drug Patent Profile
✉ Email this page to a colleague
When do Drizalma patents expire, and what generic alternatives are available?
Drizalma is a drug marketed by Sun Pharm and is included in one NDA. There are five patents protecting this drug.
The generic ingredient in DRIZALMA is duloxetine hydrochloride. There are forty-two drug master file entries for this compound. Forty-three suppliers are listed for this compound. Additional details are available on the duloxetine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Drizalma
A generic version of DRIZALMA was approved as duloxetine hydrochloride by AUROBINDO PHARMA LTD on December 11th, 2013.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for DRIZALMA?
- What are the global sales for DRIZALMA?
- What is Average Wholesale Price for DRIZALMA?
Summary for DRIZALMA
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Drug Prices: | Drug price information for DRIZALMA |
| DailyMed Link: | DRIZALMA at DailyMed |


